SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-22-032805
Filing Date
2022-11-18
Accepted
2022-11-17 21:56:54
Documents
76

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 3621905
2 ex23-2.htm EX-23.2 4146
3 forms-1_001.jpg GRAPHIC 5216
  Complete submission text file 0001493152-22-032805.txt   12728463

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ensc-20220930.xsd EX-101.SCH 65543
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ensc-20220930_cal.xml EX-101.CAL 77699
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ensc-20220930_def.xml EX-101.DEF 306851
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ensc-20220930_lab.xml EX-101.LAB 567290
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ensc-20220930_pre.xml EX-101.PRE 456167
70 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 2176676
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-268038 | Film No.: 221400451
SIC: 2834 Pharmaceutical Preparations